Cathrine Lund Lorentzen

903 citations
11 papers · 628 indexed · 1 hit paper · h-index 7
Topics
CAR-T cell therapy research (8 papers)Immunotherapy and Immune Responses (8 papers)Cancer Immunotherapy and Biomarkers (6 papers)
Partner nations
DenmarkNetherlands

In The Last Decade

Cathrine Lund Lorentzen

9 papers receiving 616 citations

Hit Papers

Clinical advances and ongoing trials of mRNA vaccines for...20222026202320242022100200300

Peers

Cathrine Lund Lorentzen
Comparison fields: 5 of 67
  • Immunology 384
  • Molecular Biology 308
  • Oncology 299
  • Genetics 54
  • Cancer Research 46
Replace Patrícia Cruz Bergami-Santos with:
Patrícia Cruz Bergami-Santos Brazil
Ane Orrantia Spain
Kanstantsin V. Katlinski United States
Jenny Sprooten Belgium
Bas Pilzecker Netherlands
Morgan Grau France
Suzan Lazo United States
Jens Pahl Germany
Aaron Y. Chang United States
Rosanna M. McEwen-Smith United Kingdom
Cathrine Lund Lorentzen relative to Patrícia Cruz Bergami-Santos Brazil Patrícia Cruz Bergami-Santos's profile →
Citations per field
00.5×3.6×
Patrícia Cruz Bergami-Santos · 1×
Citations per year

Countries citing papers authored by Cathrine Lund Lorentzen

Since Specialization
Citations

This map shows the geographic impact of Cathrine Lund Lorentzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathrine Lund Lorentzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathrine Lund Lorentzen more than expected).

Fields of papers citing papers by Cathrine Lund Lorentzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathrine Lund Lorentzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathrine Lund Lorentzen. The network helps show where Cathrine Lund Lorentzen may publish in the future.

Co-authorship network of co-authors of Cathrine Lund Lorentzen

This figure shows the co-authorship network connecting the top 25 collaborators of Cathrine Lund Lorentzen. A scholar is included among the top collaborators of Cathrine Lund Lorentzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathrine Lund Lorentzen. Cathrine Lund Lorentzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 20
3 36
4
Clinical advances and ongoing trials of mRNA vaccines for cancer treatmentbreakdown →
346
5 1
6 45
7 135
8 12
9 1
10 2
11 30

About Cathrine Lund Lorentzen

Cathrine Lund Lorentzen is a scholar working on Immunology, Oncology and Biotechnology, having authored 11 papers that have together received 628 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Immunology (384 citations), Oncology (299 citations) and Biological Psychiatry (22 citations). Cathrine Lund Lorentzen has collaborated with scholars based in Denmark and Netherlands. Frequent co-authors include Inge Marie Svane, Özcan Met, John B.A.G. Haanen, Julie Westerlin Kjeldsen, Mads Hald Andersen, E. Ehrnrooth, Per thor Straten, Evelina Martinenaite, Marco Donia and Ayako Wakatsuki Pedersen. Their work appears in journals such as Nature Medicine, Nature Communications and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026